'It's concerning to see that five-year survival rates
for some of the most common cancers show little evidence of improvement in recent years,' said Dr Fran Woodward, Macmillan's executive director of policy and impact.
However, the study revealed that in new markets such as Cambodia, Laos and Myanmar, the export products of Philippine MSMEs had low survival rates
, averaging 41 percent after year one.
Guillaumont (2009) mention that under-five survival rate
best indictor to represent social progress of nation.
In this study, we found that age, sex, smoking, histopathologic type, anatomic localization, stage, resection type, and postoperative complications did not affect survival rates
. Patients with incomplete resection or metastases in the follow-up period had significantly lower survival rates
While, in most cases, the percentages are very marginal, Wales has performed worse than England in the survival rates
of many cancer types in 2010-14.
The survival rate
of brook trout was found to be similar in both mono- and duoculture.
At the event, Mr Morris was presented with the cancer survival rates
for Durham Dales, Easington and Sedgefield Clinical Commissioning Group showing that 67% of local people with cancer will live for a year after diagnosis.
The one-year survival rate
for men with lung cancer in Cheshire, Warrington and Wirral was just 23.7%, the lowest rate in England.
The present research was made under the climatic conditions of Sivas Province and recorded the early survival rates
of live born puppies of the Kangal breed with the aim of determining the effects of several factors such as age of dam litter size weather conditions birth place puppy sex and age on the survival rate
of the puppies.
KEYWORDS: Survival rate
, Pediatric renal transplantation, Cox regression model, Kaplan-Meier.
According to Slome, the five year cancer survival rate
for white Americans has been steadily increasing from 61.5 percent for the time period 1990-1992 until today.
3 October 2011 - US EntreMed Inc (NASDAQ:ENMD) unveiled today the final data for the primary endpoint of progression free survival rate
at six months for its Phase II trial with ENMD-2076 in platinum-resistant ovarian cancer patients.